APO RESEARCH · REPORT
Femoral Cannula
Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.
Product & engineering
Understand the product.
Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.
When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.
Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.
Selected research
Industry Research
Femoral Cannula Industry Research Report 2026
Market perspective
Femoral arteriovenous cannula provides temporary support for extracorporeal circulation and gas exchange to replace heart or lung function as a bridge for resuscitation or other long-term support.
When intubated through the femoral and internal jugular veins, blood is drawn through the femoral or internal jugular vein catheter and pumped through membrane oxygenators to remove carbon dioxide, increase oxygen, and provide temperature control.
Partial to complete extracorporeal lung support is provided to maintain adequate oxygenation and normal blood flow.
Read the full market overview
Globally, major manufacturers of femoral arteriovenous systems include Medtronic, Edward Lifescience, LivaNova, Surge Cardiovascular, Kangxin, Xenios AG, and Chalice Medical.
The main producers are mainly in Europe and the United States.
Report Scope
This report quantifies the global Femoral Cannula market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Femoral Cannula Market by Company
Medtronic
Edward Lifescience
LivaNova
Surge Cardiovascular
Changzhou KangXin Medical Instruments Co., Ltd.
Chalice Medical Ltd.
Xenios AG
Femoral Cannula Segment by Type
Unipolar
Bipolar
Femoral Cannula Segment by Application
Traditional extracorporeal circulation surgery
Extracorporeal membrane oxygenation (ECMO)
Hemodialysis
Other
Femoral Cannula Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Femoral Cannula market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Femoral Cannula and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Femoral Cannula.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Femoral Cannula manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Femoral Cannula by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Femoral Cannula in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Unipolar
- Bipolar
Applications
- Traditional extracorporeal circulation surgery
- Extracorporeal membrane oxygenation (ECMO)
- Hemodialysis
- Other
Companies covered
- Medtronic
- Edward Lifescience
- LivaNova
- Surge Cardiovascular
- Changzhou KangXin Medical Instruments Co., Ltd.
- Chalice Medical Ltd.
- Xenios AG
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Femoral Cannula Market Size (2021-2032)
- 2.2.2 Global Femoral Cannula Sales (2021-2032)
- 2.2.3 Global Femoral Cannula Market Average Price (2021-2032)
- 2.3 Femoral Cannula by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Unipolar
- 2.3.3 Bipolar
- 2.4 Femoral Cannula by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Traditional extracorporeal circulation surgery
- 2.4.3 Extracorporeal membrane oxygenation (ECMO)
- 2.4.4 Hemodialysis
- 2.4.5 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Femoral Cannula Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Femoral Cannula Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Femoral Cannula Revenue of Manufacturers (2021-2026)
- 3.4 Global Femoral Cannula Average Price by Manufacturers (2021-2026)
- 3.5 Global Femoral Cannula Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Femoral Cannula, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Femoral Cannula, Product Type & Application
- 3.8 Global Manufacturers of Femoral Cannula, Established Date
- 3.9 Global Femoral Cannula Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Medtronic
- 4.1.1 Medtronic Company Information
- 4.1.2 Medtronic Business Overview
- 4.1.3 Medtronic Femoral Cannula Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Medtronic Femoral Cannula Product Portfolio
- 4.1.5 Medtronic Recent Developments
- 4.2 Edward Lifescience
- 4.2.1 Edward Lifescience Company Information
- 4.2.2 Edward Lifescience Business Overview
- 4.2.3 Edward Lifescience Femoral Cannula Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Edward Lifescience Femoral Cannula Product Portfolio
- 4.2.5 Edward Lifescience Recent Developments
- 4.3 LivaNova
- 4.3.1 LivaNova Company Information
- 4.3.2 LivaNova Business Overview
- 4.3.3 LivaNova Femoral Cannula Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 LivaNova Femoral Cannula Product Portfolio
- 4.3.5 LivaNova Recent Developments
- 4.4 Surge Cardiovascular
- 4.4.1 Surge Cardiovascular Company Information
- 4.4.2 Surge Cardiovascular Business Overview
- 4.4.3 Surge Cardiovascular Femoral Cannula Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Surge Cardiovascular Femoral Cannula Product Portfolio
- 4.4.5 Surge Cardiovascular Recent Developments
- 4.5 Changzhou KangXin Medical Instruments Co., Ltd.
- 4.5.1 Changzhou KangXin Medical Instruments Co., Ltd. Company Information
- 4.5.2 Changzhou KangXin Medical Instruments Co., Ltd. Business Overview
- 4.5.3 Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Changzhou KangXin Medical Instruments Co., Ltd. Femoral Cannula Product Portfolio
- 4.5.5 Changzhou KangXin Medical Instruments Co., Ltd. Recent Developments
- 4.6 Chalice Medical Ltd.
- 4.6.1 Chalice Medical Ltd. Company Information
- 4.6.2 Chalice Medical Ltd. Business Overview
- 4.6.3 Chalice Medical Ltd. Femoral Cannula Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Chalice Medical Ltd. Femoral Cannula Product Portfolio
- 4.6.5 Chalice Medical Ltd. Recent Developments
- 4.7 Xenios AG
- 4.7.1 Xenios AG Company Information
- 4.7.2 Xenios AG Business Overview
- 4.7.3 Xenios AG Femoral Cannula Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Xenios AG Femoral Cannula Product Portfolio
- 4.7.5 Xenios AG Recent Developments
5 Global Femoral Cannula Market Scenario by Region
- 5.1 Global Femoral Cannula Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Femoral Cannula Sales by Region: 2021-2032
- 5.2.1 Global Femoral Cannula Sales by Region: 2021-2026
- 5.2.2 Global Femoral Cannula Sales by Region: 2027-2032
- 5.3 Global Femoral Cannula Revenue by Region: 2021-2032
- 5.3.1 Global Femoral Cannula Revenue by Region: 2021-2026
- 5.3.2 Global Femoral Cannula Revenue by Region: 2027-2032
- 5.4 North America Femoral Cannula Market Facts & Figures by Country
- 5.4.1 North America Femoral Cannula Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Femoral Cannula Sales by Country (2021-2032)
- 5.4.3 North America Femoral Cannula Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Femoral Cannula Market Facts & Figures by Country
- 5.5.1 Europe Femoral Cannula Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Femoral Cannula Sales by Country (2021-2032)
- 5.5.3 Europe Femoral Cannula Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Femoral Cannula Market Facts & Figures by Country
- 5.6.1 Asia Pacific Femoral Cannula Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Femoral Cannula Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Femoral Cannula Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Femoral Cannula Market Facts & Figures by Country
- 5.7.1 South America Femoral Cannula Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Femoral Cannula Sales by Country (2021-2032)
- 5.7.3 South America Femoral Cannula Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Femoral Cannula Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Femoral Cannula Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Femoral Cannula Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Femoral Cannula Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Femoral Cannula Sales by Type (2021-2032)
- 6.1.1 Global Femoral Cannula Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Femoral Cannula Sales Market Share by Type (2021-2032)
- 6.2 Global Femoral Cannula Revenue by Type (2021-2032)
- 6.2.1 Global Femoral Cannula Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Femoral Cannula Revenue Market Share by Type (2021-2032)
- 6.3 Global Femoral Cannula Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Femoral Cannula Sales by Application (2021-2032)
- 7.1.1 Global Femoral Cannula Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Femoral Cannula Sales Market Share by Application (2021-2032)
- 7.2 Global Femoral Cannula Revenue by Application (2021-2032)
- 7.2.1 Global Femoral Cannula Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Femoral Cannula Revenue Market Share by Application (2021-2032)
- 7.3 Global Femoral Cannula Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Femoral Cannula Value Chain Analysis
- 8.1.1 Femoral Cannula Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Femoral Cannula Production Mode & Process
- 8.2 Femoral Cannula Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Femoral Cannula Distributors
- 8.2.3 Femoral Cannula Customers
9 Global Femoral Cannula Analyzing Market Dynamics
- 9.1 Femoral Cannula Industry Trends
- 9.2 Femoral Cannula Industry Drivers
- 9.3 Femoral Cannula Industry Opportunities and Challenges
- 9.4 Femoral Cannula Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst